Skip to content

Kronox Lab Sciences Ltd.

Menu
  • Home
  • Company
    • About Us
    • Board of Directors
    • Board and Board Committees
    • Manufacturing Facility & Infrastructure
    • Enterprise Qualification
  • Products
    • Bulk Reagents
      • ACS Reagents
      • LR, AR & GR Reagents
    • Bulk Ingredients
      • Oral Care
      • Pharmacopoeia
      • Food & Nutraceutical
      • Personal Care & Cosmetics
      • Veterinary Pharma & Animal Health
    • Speciality Chemicals
      • Citrates
      • EDTA & Derivatives
      • Hydroxides
      • Hypophosphites
      • Heat Treatment, Quenching, Eutectic Salt
      • Phosphates
      • Speciality Anhydrous
      • Tartrates
      • Ultra High Purity Chemicals
      • Custom Specification
  • Quality
    • Quality Control & Assurance
  • Investors
    • Corporate Policies
    • IPO Documents
    • Industrial Report
    • Investor Grievance
    • Financials
    • Material Creditors
    • Annual Returns
    • Group Company
    • Newspaper Publications
    • Secretarial Compliance Report
    • Corporate Governance Report
    • Quarterly Results
    • Shareholding Pattern
    • Unclaimed Dividend
    • Subsidiary
    • Notice
    • Regu. 46 Disclosure
    • AGM
  • Career
  • Contact Us

INVESTORS

Menu
  • Corporate Policies
  • IPO Documents
  • Industrial Report
  • Investor Grievance
  • Financials
  • Material Creditors
  • Annual Returns
  • Group Company
  • Newspaper Publications
  • Secretarial Compliance Report
  • Corporate Governance Report
  • Quarterly Results
  • Shareholding Pattern
  • Unclaimed Dividend
  • Subsidiary
  • Notice
  • Regu. 46 Disclosure
  • AGM

INVESTORS

Home / Investors / Material Contract & Documents / Material Documents

a. Altered MOA

a1.Altered-AOA

b. COI Incorporation

c. COI - Conversion

d. BR - 23.1.2024_IPO

e. BR - 23.1.2024_OFS Noting

f. BR - 25.1.2024_DRHP Approval

G. RHP RESOLUTION 28052024

h. Consent - Selling Shareholders

i. CA Certificate - KPI

j. Audit Committee_KPI

k. CA - Eligibility Certificate

l1. FINANCIALS-FOR-2020-2021

l2. FINANCIALS-FOR-2021-2022

l3. FINANCIALS-FOR-2022-2023

m. Examination report on RFS (Dt. 16.05.2024)

n1. Consent - DIRECTORS & KMP

n2. CONSENTS

o. Consent letter - CA

p. Consent - Chartered Engineer

q. Industry Report

r. Consent - CARE

s. SEBI Due Diligence Certificate

t. NSDL Tripartite Agreement

u. CDSL Tripartite Agreements

v. BSE Approval Letter

v. NSE Approval Letter

w. SEBI Letter dated April12, 2024

Bulk Reagents

  • ACS Reagents
  • LR, AR & GR Reagents

Bulk Ingredients

  • Oral Care
  • Pharmacopoeia
  • Food & Nutraceutical
  • Personal Care & Cosmetics
  • Veterinary Pharma & Animal Health

Speciality Chemicals

  • Tartrates
  • Citrates
  • Hypophosphites
  • Phosphates
  • Hydroxides
  • EDTA & Derivatives
  • Ultra High Purity Chemicals
  • Custom Specification
  • Speciality Anhydrous

Contact Us

KRONOX Lab Sciences Ltd

Block No. 284, Village: Dabhasa, Taluka: Padra, Dist.: Vadodara Gujarat, INDIA- 391440

Phone: +91 – 2662 – 244077 / 244088

Email: sales@kronoxlabsciences.com info@kronoxlabsciences.com

Investor Grievance:
cs@kronoxlabsciences.com

Copyright © 2025 Kronox Lab Sciences Ltd.